Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. (2008)

First Author: Chan PH

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/bi8005797

PubMed Identifier: 18816062

Publication URI: http://europepmc.org/abstract/MED/18816062

Type: Journal Article/Review

Volume: 47

Parent Publication: Biochemistry

Issue: 42

ISSN: 0006-2960